Regard and Viz.ai both aim to enhance diagnostic workflows in healthcare, but differ notably in size and funding. Viz.ai has a larger company size and more robust funding at $291.5M compared to Regard's $81.4M, indicating greater market penetration and potential resources for integration and support. Both tools rely on AI but have different focuses, with Viz.ai specializing in rapid care coordination, evidenced by its extensive integration with EHR and imaging systems.
Best for
Regard is the better choice when a healthcare team needs seamless integration with telemedicine and wearable technology to support diagnostic precision and proactive documentation.
Best for
Viz.ai is the better choice when rapid diagnosis and treatment coordination, such as for stroke or heart attack, are critical due to its robust EHR and imaging system integrations and real-time data capabilities.
Key Differences
Verdict
Regard is optimal for healthcare teams focusing on comprehensive documentation and diagnostics with wearable tech integration, especially when budget constraints are tighter. Viz.ai, with its extensive resources and integrations, is better suited for larger institutions prioritizing rapid AI-driven care coordination and treatment management. Decision-makers should consider team size and specific operational needs when selecting between the two.
Regard
Regard reviews all data in the medical record to recommend diagnoses and generate a complete note at the point of care - improving care, quality, and
The reviews and social mentions do not provide any specific feedback or insights about "Regard", making it challenging to discern user opinions on the software. Given the lack of detailed user input, it is difficult to outline the main strengths, key complaints, pricing sentiment, or overall reputation of the tool. More targeted user feedback would be needed for a comprehensive analysis.
Viz.ai
Viz.ai closes the gaps between patients, clinicians, and life-saving treatments with its leading-edge AI-powered care coordination solution.
Based on sparse data from the social mentions and lack of detailed reviews, it's challenging to provide a comprehensive summary of user opinions on Viz.ai. However, the repeated mentions of "Viz.ai AI" on platforms like YouTube might suggest a growing interest or engagement with the software, potentially highlighting its relevance within the AI community. Overall, without specific user reviews or pricing details, the software's strengths, complaints, and pricing sentiments remain unclear. The mentions seem to indicate a neutral to positive reputation but require more context for a definitive assessment.
Regard
-50% vs last weekViz.ai
-75% vs last weekRegard
Viz.ai
Regard
Viz.ai
Regard
Pricing found: $7
Viz.ai
Regard (2)
Viz.ai (8)
Only in Regard (2)
Only in Viz.ai (2)
Only in Regard (8)
Only in Viz.ai (15)
Regard
Viz.ai
Regard
Viz.ai
Regard
Viz.ai
Regard
Viz.ai
Regard
Slop is making me feel disconnected from AI Research [D]
Hello everyone. This is just a small rant on my part. I’m relatively young, a final year undergrad, and I’ve been interested in AI researcher since I was in high school. Over that period of time I feel there has been a significant shift in the landscape regarding the culture surrounding the research
Viz.ai
Shared (1)
Viz.ai is better for stroke diagnosis as it focuses on rapid care coordination with real-time data integration, essential for timely intervention.
Regard offers a starting price of $7 with tiered pricing, whereas Viz.ai's pricing is unspecified, potentially indicating a tailored pricing approach.
Viz.ai likely has better community support given its larger company size and greater funding, although specific user feedback is limited.
The tools could potentially complement each other; Viz.ai for acute diagnosis coordination and Regard for comprehensive documentation and diagnostics.
Regard might be easier to start with due to its specific tiered pricing and focus on EHR integration, simplifying initial deployment decisions.
